Method of forming a tubular membrane on a structural frame
View Patent ↗The present invention relates to a medical device and method of forming the medical device. In particular, the present invention relates to a medical device having a tubular membrane structure over a radially expandable structural frame, and to a method of forming the tubular membrane on the radially expandable structural frame. In one aspect, a structural frame is placed over a spinning mandrel and a fiber is electro-statically spun over at least a portion of the structural frame forming a membrane. A transfer sheath may be used between the mandrel and structural frame to prevent the electro-statically spun fiber from adhering to the mandrel. In another aspect, a first membrane is spun over the mandrel before the structural frame is placed over the mandrel. In this aspect, at least a portion of the structural frame is sandwiched between the membranes. The membrane or membranes and structural frame form a fiber spun frame assembly. The fiber spun frame assembly may be coated with an elastic polymer. In addition, the membrane or membranes may go through some post processing to achieve desired characteristics or configurations.
1. A method of forming a tubular membrane on a radially expandable structural frame, the method comprising the steps of:
placing a transfer sheath over a spinning mandrel;
placing the radially expandable structural frame directly onto the transfer sheath;
electro-statically spinning a fiber directly onto at least a portion of the structural frame to form a tubular membrane, the structural frame and tubular membrane forming a fiber spun frame assembly;
forming valve cusps in the tubular membrane, and thinning the tubular membrane to form valve flaps;
and removing the fiber spun frame assembly from the spinning mandrel.
2. The method of claim 1 wherein the step of electro-statically spinning a fiber directly onto the structural frame comprises the steps of:
creating an electrical potential between a fiber forming liquid and a downstream component, whereby the fiber forming liquid is caused to produce a charged fiber;
hardening the fiber by introducing a chemical hardener into the fiber forming liquid;
and collecting the hardened fiber on the structural frame.
3. The method of claim 2 wherein the fiber forming liquid is a polymer.
4. The method of claim 3 wherein the polymer is a fluoropolymer.
5. The method of claim 4 wherein the fluoropolymer is vinylidene fluoride/hexafluoropropylene having a weight to weight ratio of between 75%/25% and 100%/0%.
6. The method of claim 3 wherein the polymer is a bioabsorbable polymer.
7. The method of claim 6 wherein the bioabsorbable polymer is a polylactic acid/polycaprolactone having a weight to weight ratio of between 50%/50% and 70%/30%.
8. The method of claim 6 wherein the bioabsorbable polymer is a polyglycolic acid/polycaprolactone having a weight to weight ratio of between 50%/50% and 70%/30%.
9. The method of claim 3 wherein the polymer comprises a bioabsorbable polymer from the group consisting of homopolymers and copolymers.
10. The method of claim 2 further comprising adding a therapeutic agent to the fiber forming liquid before electrostatically spinning the fiber.
11. The method of claim 2 further comprising adding a pharmaceutic agent to the fiber forming liquid before electrostatically spinning the fiber.
12. The method of claim 2 wherein the step of collecting the hardened fiber on the structural frame comprises:
electrically attracting the fiber forming liquid to a downstream component; and rotating the structural frame about its longitudinal axis by spinning the spinning mandrel.
13. The method of claim 1 further comprising coating the fiber spun frame assembly with a polymer solution.
14. The method of claim 13 wherein the polymer solution is a fluoropolymer.
15. The method of claim 14 wherein the fluoropolymer is a vinylidene fluoride/hexofluoropropylene having a weight to weight radio of between 50%/50% to 70%/30%.
16. The method of claim 13 wherein the polymer solution is non-siliconized polyurethane.
17. The method of claim 13 wherein the polymer solution comprises a therapeutic agent.
18. The method of claim 13 wherein the polymer solution comprises a pharmaceutic agent.
19. The method of claim 1 further comprising reshaping at least a portion of the tubular membrane after the fiber is spun to provide a thickened, rigid region.
20. A method of forming a tubular membrane on a radially expandable structural frame, the method comprising the steps of: placing the radially expandable structural frame directly onto a spinning mandrel; electro-statically spinning a first fiber directly onto at least a portion of the structural frame to form a tubular membrane, the structural frame and tubular membrane forming a fiber spun frame assembly; forming valve cusps in the tubular membrane and thinning the tubular membrane in the area of the valve cusps to form valve flaps; and removing the fiber spun frame assembly from the spinning mandrel.